Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Fallopian Tube Cancer
Related studies linked through entity extraction aliases.
Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
- Status
- RECRUITING
- Phase
- PHASE2
Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Surgery for Relapsed Ovarian Cancer in Precision
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Diet, Hepcidin, and Chemotherapy RDI
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
- Status
- RECRUITING
- Phase
- PHASE1
Nudge to Gynecologic Oncology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Early Detection of Relapse in Ovarian Cancer Using Capillary Home-sampling and a Protein Biomarker Test
- Status
- RECRUITING
- Phase
- N/A
Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery
- Status
- RECRUITING
- Phase
- PHASE2
Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study
- Status
- COMPLETED
- Phase
- N/A
Choices About Genetic Testing And Learning Your Risk With Smart Technology
- Status
- COMPLETED
- Phase
- NA
RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Sovilnesib in Subjects With Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy
- Status
- RECRUITING
- Phase
- N/A
HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer
- Status
- RECRUITING
- Phase
- PHASE2